Lipocalins and insulin resistance: Etiological role of retinol-binding protein 4 and lipocalin-2?

Clinical Chemistry

Volumn 53, Issue 1, 2007, Pages 5-7

  Van Dam, Rob M ^a   Hu, Frank B ^b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

LIPOCALIN; LIPOCALIN 2; RETINOL BINDING PROTEIN; RETINOL BINDING PROTEIN 4; UNCLASSIFIED DRUG;

CARDIOVASCULAR DISEASE; DISEASE ASSOCIATION; EDITORIAL; GLUCOSE METABOLISM; HUMAN; INSULIN RESISTANCE; LIPID STORAGE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOGENESIS;

ACUTE-PHASE PROTEINS; ADIPOSE TISSUE; ANIMALS; BODY MASS INDEX; C-REACTIVE PROTEIN; HUMANS; INFLAMMATION; INSULIN RESISTANCE; LIVER; MICE; MICE, OBESE; OBESITY; ONCOGENE PROTEINS; PPAR GAMMA; PROTO-ONCOGENE PROTEINS; RETINOL-BINDING PROTEINS; THIAZOLIDINEDIONES;

EID: 33845990292     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2006.080432     Document Type: Editorial

References (15)

1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-53.
2. Ronti T, Lupattelli G, Mannarino E. The endocrine function of adipose tissue: an update. Clin Endocrinol (Oxf) 2006;64:355-65.
3. Borregaard N, Cowland JB. Neutrophil gelatinase-associated lipocalin, a siderophore-binding eukaryotic protein. Biometals 2006;19:211-5.
4. Yang Q, Graham TE, Mody N, Preitner F, Peroni OD, Zabolotny JM, et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 2005;436:356-62.
5. Graham TE, Yang Q, Bluher M, Hammarstedt A, Ciaraldi TP, Henry RR, et al. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med 2006;354:2552-63.
6. Wang Y, Lam KS, Kraegen EW, Sweeney G, Zhang J, Tso AWK, et al. Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans. Clin Chem 2007;53:34-41.
7. Flo TH, Smith KD, Sato S, Rodriguez DJ, Holmes MA, Strong RK, et al. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 2004;432:917-21.
8. Meyer C, Pimenta W, Woerle HJ, Van Haeften T, Szoke E, Mitrakou A, et al. Different mechanisms for impaired fasting glucose and impaired postprandial glucose tolerance in humans. Diabetes Care 2006;29:1909-14.
9. Takashima N, Tomoike H, Iwai N. Retinol-binding protein 4 and insulin resistance [Comment]. N Engl J Med 2006;354:1392.
10. Erikstrup C, Mortensen OH, Pedersen BK. Retinol-binding protein 4 and insulin resistance [Comment]. N Engl J Med 2006;355:1393-4.
11. Janke J, Engeli S, Boschmann M, Adams F, Bohnke J, Luft FC, et al. Retinol-binding protein 4 in human obesity. Diabetes 2006;55:2805-10.
12. Meade TW, Humphries SE, De Stavola BL. Commentary: fibrinogen and coronary heart disease-test of causality by 'Mendelian' randomization by Keavney et al. Int J Epidemiol 2006;35:944-7.
13. Ballantyne CM, Nambi V. Markers of inflammation and their clinical significance. Atheroscler Suppl 2005;6:21-9.
14. Hu FB, Willett WC. Optimal diets for prevention of coronary heart disease. JAMA 2002;288:2569-78.
15. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343-50.